Literature DB >> 3984493

Sialic acid is incorporated into influenza hemagglutinin glycoproteins in the absence of viral neuraminidase.

S Basak, M Tomana, R W Compans.   

Abstract

We have analyzed the pronase-derived glycopeptides of the hemagglutinin glycoproteins expressed from SV40 vectors carrying cloned cDNA copies of the HA gene and of HA isolated from influenza virions (A/Jap/305/57). The glycopeptides derived from he HA glycoprotein obtained from cloned genes were heterogeneous, ranging in size from 3800 to 2800 daltons. Upon treatment with neuraminidase, sialic acid was released from the glycopeptides and their size was reduced to 2900-2400 daltons. However, under the same conditions, no sialic acid was detected in the virion HA. The presence of sialic acid was confirmed by monosaccharide analysis of the HA glycoprotein derived from products of cloned genes. These results support the idea that during replication of influenza virus, the viral neuraminidase cleaves sialic acid from the HA glycoprotein in infected cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3984493     DOI: 10.1016/0168-1702(85)90060-7

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  17 in total

1.  A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range.

Authors:  J Dong; M G Roth; E Hunter
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

2.  Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase.

Authors:  P M Colman; P A Hoyne; M C Lawrence
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

3.  Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.

Authors:  Vasiliy P Mishin; Dmitri Novikov; Frederick G Hayden; Larisa V Gubareva
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus.

Authors:  S Li; J Schulman; S Itamura; P Palese
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

Review 5.  Challenges of Making Effective Influenza Vaccines.

Authors:  Sigrid Gouma; Elizabeth M Anderson; Scott E Hensley
Journal:  Annu Rev Virol       Date:  2020-05-11       Impact factor: 10.431

6.  Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry.

Authors:  Jacqueline P Upham; Danielle Pickett; Tatsuro Irimura; E Margot Anders; Patrick C Reading
Journal:  J Virol       Date:  2010-01-27       Impact factor: 5.103

7.  Accessing and Assessing the Cell-Surface Glycocalyx Using DNA Origami.

Authors:  Piyumi Wijesekara; Ying Liu; Weitao Wang; Elizabeth K Johnston; Mara L G Sullivan; Rebecca E Taylor; Xi Ren
Journal:  Nano Lett       Date:  2021-05-24       Impact factor: 11.189

8.  Cell-Culture Adaptation of H3N2 Influenza Virus Impacts Acid Stability and Reduces Airborne Transmission in Ferret Model.

Authors:  Valerie Le Sage; Karen A Kormuth; Eric Nturibi; Juhye M Lee; Sheila A Frizzell; Michael M Myerburg; Jesse D Bloom; Seema S Lakdawala
Journal:  Viruses       Date:  2021-04-21       Impact factor: 5.048

Review 9.  Soluble host defense lectins in innate immunity to influenza virus.

Authors:  Wy Ching Ng; Michelle D Tate; Andrew G Brooks; Patrick C Reading
Journal:  J Biomed Biotechnol       Date:  2012-05-16

Review 10.  The battle between influenza and the innate immune response in the human respiratory tract.

Authors:  John M Nicholls
Journal:  Infect Chemother       Date:  2013-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.